Products Under Development

THESE PRODUCTS ARE CURRENTLY UNDER DEVELOPMENT AND INVESTIGATIONAL USE ONLY AND ARE NOT AVAILABLE FOR COMMERCIAL DISTRIBUTION AS OF THIS TIME. PLEASE CONTACT ACCUTECH IF YOU WISH TO PARTICIPATE IN A CONTROLLED INVESTIGATIONAL CLINICAL STUDY.

AccuTech Products Under Development

CRPSCREEN®

Will be a quick semi-quantitave, screening method for heart disease risk potential with regard to chronic inflammation. Rapid C-Reactive Protein test provides physicians a one-step device for screening heart disease risk potential in 4 minutes.

CRPTRAK®

Will be a quick fully quantitave, measurement for monitoring the inflammation. Fully Quantitative, rapid C-Reactive Protein test offers physicians a one-step device for critical CRP measurement with results in 15 minutes. (range 3 - 30 mg/L).

GLUCOSETRAK®

Will be for early detection of diabetes & pre-diabetes. This investigational device will help 41 million pre-diabetic Americans who may become diabetic. Quantitative tests to measure glucose level for early detection for diabetes and pre-diabetes. Best tool to measure 2-hr OGTT (Oral Glucose Tolerance Test) and keep it in check.

PSASCREEN® - Prostate Cancer Screen

Will be a rapid test for measuring Prostate Specific Antigen (PSA) in the bloodstream. Early detection of Prostate Cancer in 4 minutes.

OEM - Therapeutic Analytic

We will create your OEM projects. Combine our proprietary technology with your specified needs for detection of drug level to accelerate drug discovery or patient treatment.

For the latest clinical/investigational availability on these new products under development, contact AccuTech at info@accutech-llc.com.

home cholestrak accumeter new products news order contact